Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ned Tijdschr Geneeskd ; 141(4): 204-5, 1997 Jan 25.
Article in Dutch | MEDLINE | ID: mdl-9064530

ABSTRACT

The Netherlands' Ministry of Health and the health insurance companies have drawn up a list of preparations which will no longer be reimbursed. The ocular antibiotic preparations Polyspectran and Terramycin are on the list. However, there are no satisfactory alternative with respect to the broadness of the antibiotic spectrum required. In addition, some alternatives have serious side effects or may induce bacterial resistance.


Subject(s)
Drug Therapy, Combination/economics , Insurance, Health, Reimbursement , Ophthalmic Solutions/economics , Anti-Bacterial Agents/economics , Bacitracin/economics , Drug Therapy, Combination/administration & dosage , Gramicidin/economics , Humans , Neomycin/economics , Netherlands , Oxytetracycline/economics , Polymyxin B/economics
SELECTION OF CITATIONS
SEARCH DETAIL
...